Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover fully replicate bioequivalence study of atorvastatin calcium 80 mg under fasting conditions
TCTR20161121002Not yet recruiting
- Sponsor
- Ranbaxy Laboratories
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of atorvastatin in hypercholesterolemia, sponsored by Ranbaxy Laboratories. Primary endpoint: Pharmacokinetic bioequivalence of atorvastatin. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20161121002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161121002.